Track topics on Twitter Track topics that are important to you
2440 Camino Ramon, Suite 300
United States of America
Phone: 1 (925) 543-5400
Fax: 1 (925) 543-5401
Science and health information analytics business Elsevier has finalised the name of six companies that will join its innovation hub...Read More... The post Elsevier adds six start-ups to its pharma i...
Start-ups working on a range of technologies and discoveries — from AI to immunotherapy — receive complimentary access to Elsevier's information solutions to accelerate innovation
(Elsevier) Two new chemistry solutions that use guava leaves to combat food spoilage and turn fish bones into phosphate rich fertilizer won the Elsevier Foundation Green and Sustainable Chemistry Chal...
Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation
A new analysis of safety reporting data by analytics group Elsevier and Bayer has found that some animal tests are far more predictive of human response than others.
Elsevier, the information analytics business specializing in science and health, has launched Mendeley Data, a new, cloud-based platform designed to help universities and researchers manage, share and...
SolveBio and Elsevier, the information analytics company, have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated ...
Elsevier, the information analytics business specializing in science and health, and part of RELX Group, today announced that it has acquired Via Oncology, a Pittsburgh, Pennsylvania-based company t...
This article has been removed: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been removed at the request ...
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the co-Editors-in...
THE GENETICS AND EVOLUTION OF INFECTIOUS DISEASESThe Genetics and Evolution of Infectious Diseases. Second Edition. By M. Tibayrenc (editor). Elsevier, Amsterdam, the Netherlands. 2017. 667 pp. ISBN: 978-0-12-799942-5. US $190 hardback.
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...
Reed Elsevier is a world leading publisher of information and solutions for professional users operating in four core markets: Science & MedicalLegalEducationBusinessIn February 2006, Reed Elsevier re...
Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quali...
We have published hundreds of Elsevier MDL news stories on BioPortfolio along with dozens of Elsevier MDL Clinical Trials and PubMed Articles about Elsevier MDL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elsevier MDL Companies in our database. You can also find out about relevant Elsevier MDL Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...